SCID Labs - EQA Registration
This is a contract result notice, not an open opportunity. Details from the official award data.
The procurement contact named on the official notice.
This is for the continued support of screening for Severe Combined Immunodeficiency (SCID) as part of the In-Service Evaluation (ISE).
The seven regional newborn blood spot screening laboratories participating in the SCID ISE are: Great Ormond Street Hospital (GOSH) South West Thames South East Thames (Synnovis) Newcastle * Manchester Birmingham Sheffield * Newcastle lab's EQA tests the two SCID methodologies.
What the notice asks for
This is for the continued support
This is for the continued support of screening for Severe Combined Immunodeficiency (SCID) as part of the In-Service Evaluation (ISE).
Sentences from the notice that state an obligation, surfaced automatically and shown in the order they appear. Not an exhaustive list — always confirm against the tender documents.
Make the case to bid
Reveal who to approach at NHS England, Leeds, and generate a go-to-market strategy from their news, accounts and people.
Free to start. Named contacts come from published notices; the strategy is generated from the buyer’s news, accounts and people.
- OCID
- ocds-h6vhtk-04ef46
- Stage
- award · Awarded
- Source
- Find a Tender
- Buyer ref
- 016877-2025
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
NHS England, Leeds’s tender network